| 000 | 01828 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515174626.0 | ||
| 264 | 0 | _c20091030 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1179-1950 | ||
| 024 | 7 |
_a10.2165/00003495-200969090-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHanania, Nicola A | |
| 245 | 0 | 0 |
_aEfficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. _h[electronic resource] |
| 260 |
_bDrugs _cJun 2009 |
||
| 300 |
_a1205-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xadverse effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlbuterol _xtherapeutic use |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aDyspnea _xcomplications |
| 650 | 0 | 4 |
_aEthanolamines _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aForced Expiratory Volume _xphysiology |
| 650 | 0 | 4 | _aFormoterol Fumarate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aScopolamine Derivatives _xadverse effects |
| 650 | 0 | 4 | _aSpirometry |
| 650 | 0 | 4 | _aTiotropium Bromide |
| 700 | 1 | _aBoota, Ahmad | |
| 700 | 1 | _aKerwin, Edward | |
| 700 | 1 | _aTomlinson, LaTanya | |
| 700 | 1 | _aDenis-Mize, Kimberly | |
| 773 | 0 |
_tDrugs _gvol. 69 _gno. 9 _gp. 1205-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003495-200969090-00005 _zAvailable from publisher's website |
| 999 |
_c18956135 _d18956135 |
||